SHORT REPORTS |
Neuroscience and Psychiatry Unit, University of Manchester
Merseycare NHS Trust
The Spinney, Partnerships in Care, Atherton, Manchester
Bolton, Salford & Trafford Mental Health NHS Trust, UK
Correspondence: Correspondence: Dr Ian Anderson, Neuroscience and Psychiatry Unit, Room G907, Stopford Building, Oxford Road, Manchester M13 9PT, UK. Tel: +44 (0)161 275 7428; fax: +44 (0)161 275 7429; email: ian.anderson{at}manchester.ac.uk
The place of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression remains unclear. In this sham-controlled study we determined the efficacy and acceptability offast, left frontal rTMS given three times a week over 46 weeks to 29 patients with depression (79% treatment-resistant). The procedure was generally well tolerated and more effective than sham treatment (55 v.77% responding, P<0.05), with improvement maintained to 12 weeks. This therapy could be a useful addition to available treatments but further research is needed to determine the optimum treatment parameters.
Related articles in BJP:
This article has been cited by other articles:
![]() |
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol, June 1, 2008; 22(4): 343 - 396. [Abstract] [PDF] |
||||
![]() |
U. HERWIG, A. J. FALLGATTER, J. HOPPNER, G. W. ESCHWEILER, M. KRON, G. HAJAK, F. PADBERG, A. NADERI-HEIDEN, B. ABLER, P. EICHHAMMER, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: Randomised multicentre trial The British Journal of Psychiatry, November 1, 2007; 191(5): 441 - 448. [Abstract] [Full Text] [PDF] |
||||